Evidence Based Science & Research
Medical marijuana has been scientifically proven to cure and relieve the symptoms of numerous medical ailments and conditions. There have been numerous studies conducted with published results noting the positive effects that medical marijuana oil can have for people facing terminal illness, chronic pain and untreatable epilepsy.
Marijuana oil has proven to be useful not only in helping to control the pain that is a common symptom of these conditions, but also can be helpful for patients dealing with the harsh side effects of the treatments for some of these diseases, like chemotherapy.
Additionally, patients suffering from "wasting syndrome" can use marijuana to increase their appetite level, with beneficial consequences for their overall health.
Our proposed medical marijuana initiative to legalise marijuana oil in Australia is a narrowly drawn initiative that would allow the medical use of marijuana for a limited class of people suffering from the following conditions: Glaucoma, Cancer and other severe, chronic debilitating conditions, like Epilepsy.
By limiting the initiative to this narrowly defined group of people who have a legitimate medical need for the positive effects of marijuana, Australian voters can feel secure that they are not being asked to legalise marijuana for the general population.
The initiative specifies limits on the amount to marijuana that individuals with qualifying conditions may keep. The amounts are only what is medically necessary for each individual, with most patients being limited to one ounce for personal use, or cultivating a few plants for their individual use.
Just as cancer patients do not receive chemotherapy in public view, there is no reason to believe that patients who qualify to use medicinal marijuana would do so in public. Most people who are terribly ill treat their medications seriously and use their medications appropriately, wisely and privately. Nonetheless, the initiative prohibits the use of marijuana in public places.
The fiscal impact of the initiative should minimal or nil. The startup costs of the program will be offset by the fee that the health department will be able to charge for processing registration applications. There will be no new bureaucracy created as the program will be run out of an existing state department.